Viewing Study NCT02991469


Ignite Creation Date: 2025-12-24 @ 11:03 PM
Ignite Modification Date: 2026-03-02 @ 4:06 AM
Study NCT ID: NCT02991469
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2016-10-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: DRI13926
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View